ProfileGDS4132 / 209218_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 37% 39% 37% 44% 45% 43% 43% 47% 37% 43% 42% 39% 32% 37% 46% 41% 35% 45% 39% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10195.846937
GSM201543Muscle PCOS pioglitazone 12192.949439
GSM201544Muscle PCOS pioglitazone 16195.315937
GSM201545Muscle PCOS pioglitazone 201123.16144
GSM201829Muscle PCOS pioglitazone 231124.7445
GSM201830Muscle PCOS pioglitazon 251115.32143
GSM201831Muscle PCOS pioglitazone 271113.39943
GSM201832Muscle PCOS pioglitazone 31123.37547
GSM201833Muscle PCOS pioglitazone 4189.448137
GSM201834Muscle PCOS pioglitazone 81111.7843
GSM201835Muscle PCOS after pioglitazone 10295.308242
GSM201836Muscle PCOS after pioglitazone 12288.320439
GSM201837Muscle PCOS after pioglitazone 16265.685932
GSM201838Muscle PCOS after pioglitazone 20284.685137
GSM201839Muscle PCOS after pioglitazone 232114.70246
GSM201840Muscle PCOS after pioglitazone 252103.64341
GSM201841Muscle PCOS after pioglitazone 27272.807835
GSM201842Muscle PCOS after pioglitazone 3297.963945
GSM201843Muscle PCOS after pioglitazone 4296.510839
GSM201844Muscle PCOS after pioglitazone 82104.84242